Celerius Prescribed drugs to current SP-3164 on the fifth Annual Focused Protein Degradation Convention
[ad_1] Celerius Prescribed drugs, Inc. HOUSTON, October 19, 2022 (Globe Newswire) — Celerius Prescribed drugs, Inc. (NASDAQ:SLRX)A clinical-stage biopharmaceutical firm that’s utilizing protein inhibition and protein degradation to develop most cancers remedies for sufferers in want of latest remedy choices, immediately introduced that Daniela Santiesteban, Ph.D., of Celerius’s Focused Protein Degradation Improvement Director, will probably … Read more